Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
Funding Amount
$2,000,000 - $2,000,000
Deadline
Forecast — dates not yet posted
Number of Awards
5
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Open to all applicant types
Overview
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of pre-clinical studies of anesthetic neurotoxicity. Multiple awards may be considered. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders.
Details
- Agency: Food and Drug Administration
- Department: Department of Health and Human Services
- Opportunity #: FOR-FD-25-009
- Expected Awards: 5
- Instrument: cooperative_agreement
Focus Areas & Funding Uses
Fields of Work
- Addiction recovery
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
Amount
Up to $250,000
Deadline
January 29, 2027
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration
Amount
Up to $200,000
Deadline
April 1, 2027
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Food and Drug Administration
Amount
Up to $300,000
Deadline
April 1, 2027
Laboratory Flexible Funding Model (LFFM)
Food and Drug Administration
Amount
Up to $1,500,000
Deadline
January 11, 2028
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Amount
Up to $600,000
Deadline
February 8, 2028
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration
Amount
Up to $1,250,000
Deadline
May 12, 2028
Ready to apply for Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed. Now let's win it.